Looking Into Alimera Sciences’s Return On Capital Employed
© Courtesy of Benzing Alimera Sciences (NASDAQ:ALIM) had sales of $1,360,000 during the third quarter, according to Benzinga Pro . Profit fell to $5.26 million, down 68.76% from last quarter. In the second quarter, Alimera Sciences posted revenue of $1,460,000, but lost $3,120,000 in profit. What is growing? Return on invested capital is a measure … Read more